FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1985296072> ?p ?o ?g. }

• W1985296072 endingPage "136" @default.
• W1985296072 startingPage "131" @default.
• W1985296072 abstract "Several studies performed before and after the introduction of fibrinolysis as a routine treatment of patients with myocardial infarction (MI) consistently showed that diabetic patients have a higher mortality in-hospital and after discharge. Women with insulin-dependent diabetes (IDD) appear to have a particularly ominous prognosis. So far, very few randomized prospective studies evaluated the effect of pharmacological treatments on prognosis of diabetic patients during acute MI: most of the information on the effect of commonly used cardiovascular drugs in diabetic patients with acute MI (AMI) has been obtained only from retrospective subgroup analyses of some of the large trials or as nonrandomized comparisons. The overview of fibrinolytic trials in acute MI found that fibrinolytic treatment was associated with a 35 days mortality of 13.6% versus 17.3% in diabetics (-21.7%) and 8.7% versus 10.2% in nondiabetics (-14.3%). Data from trials with aspirin suggest that the beneficial effect of this drug is maintained in diabetic patients with acute MI, but the optimal dosage remains undefined. Based on available evidence, beta blockers appear to be able to reduce mortality post-MI in diabetic patients, with an absolute and relative beneficial effect that is, in most cases, larger than that observed in nondiabetic patients. The pooled data from studies non beta blockers indicate a 37% mortality reduction in diabetic patients, compared to 13% in nondiabetics during the acute phase, and a 48% reduction of mortality compared to 33% in nondiabetics post-discharge. Data on outcome of diabetic patients in trials evaluating calcium antagonists are lacking, and there is a strong need for a reevaluation of data from completed trials to obtain some hints on the possible effect of these agents in this population. The long-term studies on angiotensin-converting enzyme (ACE) inhibitors in patients with left ventricular dysfunction some time after AMI have shown that the beneficial effect documented in the overall population is present also when limiting the analysis to patients with a history of diabetes, whereas the acute studies enrolling patients within 24-36 h after the onset of symptoms have shown a marked beneficial effect of ACE inhibitors in diabetic patients. For example, in the GISSI 3 study, treatment with lisinopril was associated with a decreased 6-week mortality in both IDD (11.8% versus 21.1, p < 0.05) and non-IDD (8.0% versus 10.6%, p < 0.05) patients corresponding to a 44.1% and 24.5% reduction, respectively. All these results must be taken with great caution because in no studies the effect of treatment in diabetic patients was a predefined analysis. They strongly suggest, however, that ACE inhibitors and beta blockers may be particularly beneficial during the acute phase of MI and also post-discharge, offering a strong rationale for their widespread use in diabetic patients with acute MI." @default.
• W1985296072 created "2016-06-24" @default.
• W1985296072 creator A5057489596 @default.
• W1985296072 creator A5057872974 @default.
• W1985296072 date "1997-03-01" @default.
• W1985296072 modified "2023-09-27" @default.
• W1985296072 title "Impact of pharmacological treatment on mortality after myocardial infarction in diabetic patients" @default.
• W1985296072 cites W1561801847 @default.
• W1985296072 cites W1690120260 @default.
• W1985296072 cites W1970284619 @default.
• W1985296072 cites W1976811924 @default.
• W1985296072 cites W1990422752 @default.
• W1985296072 cites W1990800912 @default.
• W1985296072 cites W1993387626 @default.
• W1985296072 cites W2008472820 @default.
• W1985296072 cites W2017751094 @default.
• W1985296072 cites W2027702390 @default.
• W1985296072 cites W2031232834 @default.
• W1985296072 cites W2043998212 @default.
• W1985296072 cites W2054124401 @default.
• W1985296072 cites W2060431351 @default.
• W1985296072 cites W2065807301 @default.
• W1985296072 cites W2065833280 @default.
• W1985296072 cites W2072433251 @default.
• W1985296072 cites W2079624245 @default.
• W1985296072 cites W2082096722 @default.
• W1985296072 cites W2083625183 @default.
• W1985296072 cites W2083772300 @default.
• W1985296072 cites W2095500449 @default.
• W1985296072 cites W2152314194 @default.
• W1985296072 cites W2322661993 @default.
• W1985296072 cites W2326132384 @default.
• W1985296072 cites W2330737959 @default.
• W1985296072 cites W2492141817 @default.
• W1985296072 cites W2727581825 @default.
• W1985296072 cites W3021438309 @default.
• W1985296072 cites W3111702274 @default.
• W1985296072 doi "https://doi.org/10.1016/s1056-8727(97)00100-1" @default.
• W1985296072 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9101399" @default.
• W1985296072 hasPublicationYear "1997" @default.
• W1985296072 type Work @default.
• W1985296072 sameAs 1985296072 @default.
• W1985296072 citedByCount "16" @default.
• W1985296072 crossrefType "journal-article" @default.
• W1985296072 hasAuthorship W1985296072A5057489596 @default.
• W1985296072 hasAuthorship W1985296072A5057872974 @default.
• W1985296072 hasConcept C126322002 @default.
• W1985296072 hasConcept C134018914 @default.
• W1985296072 hasConcept C141071460 @default.
• W1985296072 hasConcept C2776825266 @default.
• W1985296072 hasConcept C2777628954 @default.
• W1985296072 hasConcept C500558357 @default.
• W1985296072 hasConcept C555293320 @default.
• W1985296072 hasConcept C71924100 @default.
• W1985296072 hasConceptScore W1985296072C126322002 @default.
• W1985296072 hasConceptScore W1985296072C134018914 @default.
• W1985296072 hasConceptScore W1985296072C141071460 @default.
• W1985296072 hasConceptScore W1985296072C2776825266 @default.
• W1985296072 hasConceptScore W1985296072C2777628954 @default.
• W1985296072 hasConceptScore W1985296072C500558357 @default.
• W1985296072 hasConceptScore W1985296072C555293320 @default.
• W1985296072 hasConceptScore W1985296072C71924100 @default.
• W1985296072 hasIssue "2" @default.
• W1985296072 hasLocation W19852960721 @default.
• W1985296072 hasLocation W19852960722 @default.
• W1985296072 hasOpenAccess W1985296072 @default.
• W1985296072 hasPrimaryLocation W19852960721 @default.
• W1985296072 hasRelatedWork W2047967234 @default.
• W1985296072 hasRelatedWork W2064286441 @default.
• W1985296072 hasRelatedWork W2366434335 @default.
• W1985296072 hasRelatedWork W2367140913 @default.
• W1985296072 hasRelatedWork W2383009242 @default.
• W1985296072 hasRelatedWork W2437485626 @default.
• W1985296072 hasRelatedWork W2439875401 @default.
• W1985296072 hasRelatedWork W2950169628 @default.
• W1985296072 hasRelatedWork W3204761618 @default.
• W1985296072 hasRelatedWork W4214780584 @default.
• W1985296072 hasVolume "11" @default.
• W1985296072 isParatext "false" @default.
• W1985296072 isRetracted "false" @default.
• W1985296072 magId "1985296072" @default.
• W1985296072 workType "article" @default.